With a FIB‑4 score of 0.82, negative autoimmune hepatitis work‑up (including anti‑mitochondrial antibody) and normal glucose metabolism, what is the appropriate management of my abnormal liver enzymes?

Management of Abnormal Liver Enzymes with Low FIB-4 Score

With a FIB-4 of 0.82 and negative autoimmune workup, you can safely manage these abnormal liver enzymes in primary care without specialist referral, focusing on identifying the underlying cause (most likely NAFLD or ARLD) and implementing lifestyle modifications. 1

Risk Stratification and Next Steps

Your FIB-4 score of 0.82 is well below the threshold of 1.3 (for patients under 65 years) that would indicate concern for advanced fibrosis 1, 2. This low score effectively excludes significant liver fibrosis and means you do not need:

• Referral to hepatology
• Second-line fibrosis testing (such as ELF or FibroScan)
• Liver biopsy

The negative autoimmune hepatitis workup (including AMA) appropriately rules out primary biliary cholangitis and autoimmune hepatitis 3, 4.

Identifying the Underlying Cause

Since nearly 40% of adults have fatty liver on ultrasound, and abnormal ALT is the strongest predictor of this finding 1, your evaluation should focus on:

Most Likely Etiologies:

• NAFLD (Non-Alcoholic Fatty Liver Disease): Most common cause, especially if you have any metabolic risk factors (obesity, dyslipidemia, insulin resistance - though you mention normal glucose metabolism)
• ARLD (Alcohol-Related Liver Disease): Assess alcohol consumption using AUDIT-C questionnaire
  • Women: ≥35 units/week is harmful
  • Men: ≥50 units/week is harmful 1

Additional Workup to Complete:

Based on guideline recommendations 1, ensure you've checked:

• Alpha-1-antitrypsin level (for alpha-1-antitrypsin deficiency)
• Caeruloplasmin if age >3 years (for Wilson's disease)
• Celiac antibodies (tissue transglutaminase IgA)
• Hepatitis B and C serology (if not already done)
• Iron studies (ferritin, transferrin saturation for hemochromatosis)
• Liver ultrasound to assess for steatosis

Important caveat: One-quarter of adults with fatty liver are neither overweight nor excessive alcohol drinkers 1, so NAFLD remains possible even with normal BMI.

Primary Care Management Algorithm

1. Lifestyle Modifications (mainstay of NAFLD treatment) 1:

   • Reduce calorie intake
   • Increase physical activity
   • Aim for gradual, sustained weight loss (even 5-10% can improve liver enzymes)

2. Address Metabolic Risk Factors:

   • Optimize lipid management
   • Maintain healthy weight
   • Regular exercise

3. Avoid Hepatotoxins:

   • Review all medications for potential hepatotoxicity
   • Minimize alcohol consumption
   • Avoid unnecessary supplements

4. Monitoring Schedule:

   • Repeat liver enzymes in 3-6 months
   • Repeat FIB-4 in 3-5 years if risk factors persist 1
   • No need for more frequent fibrosis assessment given your low score

When to Reconsider Specialist Referral

You would need hepatology referral only if:

• FIB-4 rises to ≥1.3 (or ≥2.0 if age ≥65 years) 1, 2
• Liver enzymes worsen significantly despite lifestyle modifications
• New symptoms develop (jaundice, ascites, encephalopathy)
• Alternative diagnoses emerge requiring specialized management

Key Point: The combination of low FIB-4 and negative autoimmune markers provides strong reassurance that you do not have advanced liver disease requiring urgent intervention. The focus should be on identifying and treating the underlying cause while monitoring for progression 1, 5.